Get informed when a big investor buys or sells
+ FollowNovember 12, 2026 - AI Summary
Overvalued by 57.9% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $65.04 Billion |
|---|---|
| Enterprise Value | $75.13 Billion |
| Annual dividend | $0.51 |
| Dividend yield | 1.47% |
| Earnings per Share | $1.15 |
| Beta | 0.81 |
| Outstanding Shares | 2,173,889,390 |
| P/E Ratio | 27.45 |
|---|---|
| PEG | -54.78 |
| Price to Sales | 3.54 |
| Price to Book Ratio | 2.28 |
| Enterprise Value to Revenue | 3.5 |
| Enterprise Value to EBIT | 22.27 |
| Enterprise Value to Net Income | 39 |
| Total Debt to Enterprise | 0.18 |
| Debt to Equity | 0.43 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Merck KGaA is a venerable science and technology enterprise, headquartered in Darmstadt, Germany, where it was established in 1668. Operating as a subsidiary of E. Merck KG, the company organizes its diverse activities across three princ...